21 U.S.C. § 356–1
Accelerated approval of priority countermeasures
Exact citation match for 21 USC § 356-1
Search
Search by citation or keyword across the current edition within Title 21.
Accelerated approval of priority countermeasures
Exact citation match for 21 USC § 356-1
Expedited approval of drugs for serious or life-threatening diseases or conditions
Expedited approval of drugs for serious or life-threatening diseases or conditions
Drug products used to treat tobacco dependence
Drug products used to treat tobacco dependence
Expedited development and review of medical products for emergency uses
Expedited development and review of medical products for emergency uses
Registration of producers of drugs or devices
Registration of producers of drugs or devices
Priority review to encourage treatments for rare pediatric diseases
Priority review to encourage treatments for rare pediatric diseases
Development, submission, implementation, and assessment of National Drug Control Strategy
Development, submission, implementation, and assessment of National Drug Control Strategy
Standards for regenerative medicine and regenerative advanced therapies
Standards for regenerative medicine and regenerative advanced therapies
Susceptibility test interpretive criteria for microorganisms
Susceptibility test interpretive criteria for microorganisms
Expanded access policy required for investigational drugs
Expanded access policy required for investigational drugs
Countermeasure development, review, and technical assistance
Countermeasure development, review, and technical assistance